158 related articles for article (PubMed ID: 22993076)
1. Are ocular complications of a high-dose glucocorticoid treatment appropriately monitored in patients with rheumatic diseases?
Han BK; Yachoui R; Yi K
Rheumatol Int; 2013 Nov; 33(11):2951-2. PubMed ID: 22993076
[TBL] [Abstract][Full Text] [Related]
2. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
van der Goes MC; Jacobs JW; Boers M; Andrews T; Blom-Bakkers MA; Buttgereit F; Caeyers N; Choy EH; Cutolo M; Da Silva JA; Guillevin L; Holland M; Kirwan JR; Rovensky J; Saag KG; Severijns G; Webber S; Westhovens R; Bijlsma JW
Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
[TBL] [Abstract][Full Text] [Related]
3. Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center.
Posarelli C; Talarico R; Vella G; Passani A; Mosca M; Figus M
Clin Rheumatol; 2019 Oct; 38(10):2917-2923. PubMed ID: 31172366
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.
Carli L; Tani C; Querci F; Della Rossa A; Vagnani S; Baldini C; Talarico R; d'Ascanio A; Neri R; Tavoni AG; Bombardieri S; Mosca M
Clin Rheumatol; 2013 Jul; 32(7):1071-3. PubMed ID: 23456414
[TBL] [Abstract][Full Text] [Related]
5. Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: A retrospective cohort study.
Wallace BI; Lin P; Kamdar N; Noureldin M; Hayward R; Fox DA; Curtis JR; Saag KG; Waljee AK
Semin Arthritis Rheum; 2020 Apr; 50(2):228-236. PubMed ID: 31522762
[TBL] [Abstract][Full Text] [Related]
6. Rheumatology: What You May Have Missed in 2023.
Jalali K; Mandl LA
Ann Intern Med; 2024 May; 177(5_Supplement):S82-S90. PubMed ID: 38621248
[TBL] [Abstract][Full Text] [Related]
7. Stress Dose Steroids: Myths and Perioperative Medicine.
MacKenzie CR; Goodman SM
Curr Rheumatol Rep; 2016 Jul; 18(7):47. PubMed ID: 27351679
[TBL] [Abstract][Full Text] [Related]
8. Views on glucocorticoid therapy in rheumatology: the age of convergence.
Buttgereit F
Nat Rev Rheumatol; 2020 Apr; 16(4):239-246. PubMed ID: 32076129
[TBL] [Abstract][Full Text] [Related]
9. Ocular complications of topical, peri-ocular, and systemic corticosteroids.
Carnahan MC; Goldstein DA
Curr Opin Ophthalmol; 2000 Dec; 11(6):478-83. PubMed ID: 11141645
[TBL] [Abstract][Full Text] [Related]
10. [Glucocorticoid therapy in rheumatoid arthritis - contra].
Fiehn C
Dtsch Med Wochenschr; 2016 Oct; 141(22):1651. PubMed ID: 27824424
[TBL] [Abstract][Full Text] [Related]
11. [Case of cataract and glaucoma caused by glucocorticoid therapy].
Asperti G; Carella G; Trimarchi F
Ann Ottalmol Clin Ocul; 1968 Jun; 94(6):603-7. PubMed ID: 5758580
[No Abstract] [Full Text] [Related]
12. [Cataract-glaucoma association during prolonged systemic corticotherapy].
Jezegabel C; Poletti J
Bull Soc Ophtalmol Fr; 1977 Apr; 77(4):501-3. PubMed ID: 608254
[No Abstract] [Full Text] [Related]
13. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
Wall E; Walker-Bone K
QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
[TBL] [Abstract][Full Text] [Related]
14. Special issue on glucocorticoid therapy in rheumatic diseases: introduction.
Cutolo M; Chrousos GP; Pincus T
Neuroimmunomodulation; 2015; 22(1-2):3-5. PubMed ID: 25227248
[No Abstract] [Full Text] [Related]
15. Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.
George MD; Baker JF; Winthrop K; Hsu JY; Wu Q; Chen L; Xie F; Yun H; Curtis JR
Ann Intern Med; 2020 Dec; 173(11):870-878. PubMed ID: 32956604
[TBL] [Abstract][Full Text] [Related]
16. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid safety for treating rheumatoid arthritis.
Rasch LA; Bultink IE; van Tuyl LH; Lems WF
Expert Opin Drug Saf; 2015 Jun; 14(6):839-44. PubMed ID: 25802019
[TBL] [Abstract][Full Text] [Related]
18. Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy.
Loddenkemper K; Bohl N; Perka C; Burmester GR; Buttgereit F
Rheumatol Int; 2006 Feb; 26(4):331-6. PubMed ID: 15887044
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome].
Zhao Y; Su BG; Xiao HJ; Zhang HW; Liu XY; Wang F; Ding J
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):794-797. PubMed ID: 29045958
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids in the treatment of early and late RA.
Bijlsma JW; Boers M; Saag KG; Furst DE
Ann Rheum Dis; 2003 Nov; 62(11):1033-7. PubMed ID: 14583563
[No Abstract] [Full Text] [Related]
[Next] [New Search]
